Uterine Artery Embolization in Patients with a Large Fibroid Burden: Long-Term Clinical and MR Follow-up
Tóm tắt
Uterine artery embolization (UAE) in patients with a large fibroid burden is controversial. Anecdotal reports describe serious complications and limited clinical results. We report the long-term clinical and magnetic resonance (MR) results in a large series of women with a dominant fibroid of >10 cm and/or an uterine volume of >700 cm3. Seventy-one consecutive patients (mean age, 42.5 years; median, 40 years; range, 25–52 years) with a large fibroid burden were treated by UAE between August 2000 and April 2005. Volume reduction and infarction rate of dominant fibroid and uterus were assessed by comparing the baseline and latest follow-up MRIs. Patients were clinically followed at various time intervals after UAE with standardized questionnaires. There were no serious complications of UAE. During a mean follow-up of 48 months (median, 59 months; range, 6–106 months), 10 of 71 patients (14%) had a hysterectomy. Mean volume reduction of the fibroid and uterus was 44 and 43%. Mean infarction rate of the fibroid and overall fibroid infarction rate was 86 and 87%. In the vast majority of patients there was a substantial improvement of symptoms. Clinical results were similar in patients with a dominant fibroid >10 cm and in patients with large uterine volumes by diffuse fibroid disease. In conclusion, our results indicate that the risk of serious complications after UAE in patients with a large fibroid burden is not increased. Moreover, clinical long-term results are as good as in other patients who are treated with UAE. Therefore, a large fibroid burden should not be considered a contraindication for UAE.
Tài liệu tham khảo
Watson GMT, Walker WJ (2002) Uterine artery embolisation for treatment of symptomatic fibroids in 114 women: reduction of the fibroids and women’s view of the success of the treatment. BJOG 109:129–135
Walker WJ, Pelage PJ (2002) Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 109:1262–1272
Worthington-Kirsch RL, Popky GL, Hutchins FL (1998) Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 208:625–629
Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC (2005) Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 106(5; Pt 1):933–939
Goodwin SC, Spies JB, Worthington-Kirsch RL, Peterson E, Pron G, Li S, Myers ER, Fibroid Registry for Outcomes Data (FIBROID) Registry (2008) Steering uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol 111:22–33
Lohle PNM, Voogt M, de Vries J, van Oirschot C, Smeets A, Vervest HAM, Lampmann LEH, Boekkooi PF (2008) Long term outcome of uterine artery embolization in women with symptomatic fibroids. J Vasc Interv Radiol 19:319–326
Kim MD, Lee HS, Lee MH, Kim HJ, Cho JH, Sun HC (2008) Long-term results of symptomatic fibroids treated with uterine artery embolization: in conjunction with MR evaluation. Eur J Radiol (epub ahead of print, Dec 10)
Marret H, Cottier JP, Alonso AM, Giraudeau B, Body G, Herbreteau D (2005) Predictive factors for fibroids recurrence after uterine artery embolisation. BJOG 112:461–465
Al Fozan H, Tulandi T (2002) Factors affecting early surgical intervention after uterine artery embolization. Obstet Gynecol Surg 57:810–815
Goodwin SC, McLucas B, Lee M, Chen G, Perrella R, Vedantham S, Muir S, Lai A, Sayre JW, DeLeon M (1999) Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol 10:1159–1165
Vashisht A, Studd J, Carey A, Burn P (1999) Fatal septicaemia after fibroid embolisation. Lancet 354:307–308
Pelage JP, Le Dref O, Soyer P, Kardache M, Dahan H, Abitbol M, Merland JJ, Ravina JH, Rymer R (2000) Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology 215:428–431
Prollius A, de Vries C, Loggenberg E, du Plessis A, Nel M, Wessels PH (2004) Uterine artery embolisation for symptomatic fibroids: the effect of the large uterus on outcome. BJOG 111:239–242
Mirsadraee S, Tuite D, Nicholson A (2008) Uterine artery embolization for ureteric obstruction secondary to fibroids. Cardiovasc Interv Radiol 31:1094–1099
Firouznia K, Ghanaati H, Sanaati M, Jalali AH, Shakiba M (2008) Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications? Cardiovasc Interv Radiol 31:521–526
Siskin GP, Beck A, Schuster M, Mandato K, Englander M, Herr A (2008) Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol 19:58–65
Lampmann LE, Smeets AJ, Lohle PN (2004) Uterine fibroids: targeted embolization, an update on technique. Abdom Imaging 29:128–131
Spies J, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves S (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99:290–300
Katsumori T, Nakajima K, Mihara T (2003) Is a large fibroid a high-risk factor for uterine artery embolization? AJR Am J Roentgenol 181:1309–1314